T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fimmu.2021.780442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response
- (2021) Lauren S. Levine et al. IMMUNITY
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- An aged immune system drives senescence and ageing of solid organs
- (2021) Matthew J. Yousefzadeh et al. NATURE
- Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
- (2021) Evan W. Weber et al. SCIENCE
- Integrative bulk and single-cell profiling of pre-manufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy
- (2021) Gregory M Chen et al. Cancer Discovery
- Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial
- (2021) Jeremy S. Abramson et al. Blood Advances
- Efficacy and safety of CD19 ‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET , ZUMA ‐1, and TRANSCEND trials
- (2021) Jason R. Westin et al. AMERICAN JOURNAL OF HEMATOLOGY
- EPIDEMIOLOGICAL LANDSCAPE OF YOUNG MULTIPLE MYELOMA PATIENTS DIAGNOSED EARLIER THAN 40 YEARS: THE FRENCH EXPERIENCE.
- (2021) Alexis Caulier et al. BLOOD
- Current combinatorial CAR T cell strategies with Bruton tyrosine kinase inhibitors and immune checkpoint inhibitors
- (2021) Razan Mohty et al. BONE MARROW TRANSPLANTATION
- Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience
- (2021) Sanaz Ghafouri et al. Clinical Lymphoma Myeloma & Leukemia
- Feasibility and efficacy of CD19-targeted CAR-T cells with concurrent ibrutinib for CLL after ibrutinib failure
- (2020) Jordan Gauthier et al. BLOOD
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma
- (2020) Sattva S. Neelapu et al. BLOOD
- Value and affordability of CAR T-cell therapy in the United States
- (2020) Salvatore Fiorenza et al. BONE MARROW TRANSPLANTATION
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
- (2020) Philipp M. Roessner et al. LEUKEMIA
- Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL
- (2020) Felix Korell et al. Cells
- Impact of age‐, cancer‐, and treatment‐driven inflammation on T cell function and immunotherapy
- (2020) Kylie M. Quinn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years
- (2020) Marjorie E. Zettler et al. Journal of Geriatric Oncology
- Metabolic characteristics of CD8+ T cell subsets in young and aged individuals are not predictive of functionality
- (2020) Kylie M. Quinn et al. Nature Communications
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
- (2020) Qing Deng et al. NATURE MEDICINE
- Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells
- (2020) Rachel Elizabeth Cooke et al. Frontiers in Immunology
- Lymphoid-Biased Hematopoietic Stem Cells Are Maintained with Age and Efficiently Generate Lymphoid Progeny
- (2019) Encarnacion Montecino-Rodriguez et al. Stem Cell Reports
- Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B‐cell malignancies
- (2019) Sherilyn A. Tuazon et al. TRANSFUSION
- CD4+T help promotes influenza virus-specific CD8+T cell memory by limiting metabolic dysfunction
- (2019) Jolie G. Cullen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T cell efficacy
- (2019) Jaco A. C. van Bruggen et al. BLOOD
- High Rate of Durable Complete Remission in Follicular Lymphoma after CD19 CAR-T cell Immunotherapy
- (2019) Alexandre V. Hirayama et al. BLOOD
- Increased frequency of CD4 + PD‐1 + HLA‐DR + T cells is associated with disease progression in CLL
- (2019) Lauren Elston et al. BRITISH JOURNAL OF HAEMATOLOGY
- Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
- (2019) Hillary G. Caruso et al. JOURNAL OF NEURO-ONCOLOGY
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
- (2018) A. J. Davenport et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Age-Related Decline in Primary CD8 + T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 + T Cells
- (2018) Kylie M. Quinn et al. Cell Reports
- Reducing Ex Vivo Culture Improves the Anti-leukemic Activity of Chimeric Antigen Receptor (CAR)-T Cells
- (2018) Saba Ghassemi et al. Cancer Immunology Research
- The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer
- (2018) Xiao-Hua Luo et al. IMMUNOLOGY
- Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- (2018) Alexander I. Salter et al. Science Signaling
- CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+and CD30−Embryonal Carcinoma via Antigen-Dependent and Fas/FasL Interactions
- (2018) Lee K. Hong et al. Cancer Immunology Research
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- (2017) Tomasz Ahrends et al. IMMUNITY
- Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase–induced inflammation
- (2017) Milica Vukmanovic-Stejic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
- (2017) Cameron J. Turtle et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains
- (2017) Daniel T. Harris et al. JOURNAL OF IMMUNOLOGY
- Frontline Science: Functionally impaired geriatric CAR-T cells rescued by increased α5β1 integrin expression
- (2017) Prajna Guha et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Senescent cells: an emerging target for diseases of ageing
- (2017) Bennett G. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health?
- (2017) Joseph A. McBride et al. PLoS Pathogens
- Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
- (2016) Yi Zhu et al. AGING CELL
- Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
- (2016) Joseph A. Fraietta et al. BLOOD
- Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
- (2016) M. Sabatino et al. BLOOD
- Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy
- (2016) Madhusudhanan Sukumar et al. Cell Metabolism
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade
- (2016) H Suen et al. LEUKEMIA
- Heightened self-reactivity associated with selective survival, but not expansion, of naïve virus-specific CD8+T cells in aged mice
- (2016) Kylie M. Quinn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
- (2016) Cameron J. Turtle et al. Science Translational Medicine
- Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response
- (2016) John Reiser et al. Journal of Immunology Research
- The aged lymphoid tissue environment fails to support naïve T cell homeostasis
- (2016) Bryan R. Becklund et al. Scientific Reports
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
- (2015) D Sommermeyer et al. LEUKEMIA
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Quantification of biological aging in young adults
- (2015) Daniel W. Belsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
- (2015) Yun Bai et al. Cell Discovery
- ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
- (2014) S. Guedan et al. BLOOD
- p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells
- (2014) Sian M. Henson et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection
- (2014) M. R. Pipeling et al. JOURNAL OF IMMUNOLOGY
- Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
- (2014) C. Franceschi et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells
- (2014) Alessio Lanna et al. NATURE IMMUNOLOGY
- Molecular regulation of effector and memory T cell differentiation
- (2014) John T Chang et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy is a critical regulator of memory CD8+ T cell formation
- (2014) Daniel J Puleston et al. eLife
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- T Cell Replicative Senescence in Human Aging
- (2013) Jennifer P. Chou et al. CURRENT PHARMACEUTICAL DESIGN
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
- (2013) Madhusudhanan Sukumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of Interleukin-6 in Hematological Malignancies
- (2013) Renate Burger TRANSFUSION MEDICINE AND HEMOTHERAPY
- The Effect of Age on Thymic Function
- (2013) Donald B. Palmer Frontiers in Immunology
- Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
- (2013) Liza B John et al. OncoImmunology
- T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
- (2012) J. C. Riches et al. BLOOD
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Incident Ischemic Heart Disease in the Population-Based EPIC-Norfolk Cohort
- (2012) E. Gkrania-Klotsas et al. JOURNAL OF INFECTIOUS DISEASES
- Memory T cell inflation: understanding cause and effect
- (2012) Geraldine A. O’Hara et al. TRENDS IN IMMUNOLOGY
- CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
- (2011) D.-G. Song et al. BLOOD
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
- (2010) C. S. Hinrichs et al. BLOOD
- Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma
- (2010) R. H. Prabhala et al. BLOOD
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
- (2010) Michael J. Cannon et al. REVIEWS IN MEDICAL VIROLOGY
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- (2009) Michael C. Milone et al. MOLECULAR THERAPY
- CD28− T cells: their role in the age-associated decline of immune function
- (2009) Nan-ping Weng et al. TRENDS IN IMMUNOLOGY
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
- (2008) C. S. Hinrichs et al. BLOOD
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus
- (2008) Eric J. Yager et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search